Literature DB >> 16644207

Telomeres and telomerase in cancer stem cells.

Zhenyu Ju1, Karl Lenhard Rudolph.   

Abstract

Alterations in telomere dynamics both suppress and facilitate malignant transformation by regulating genomic stability and cell lifespan. Checkpoints induced by telomere dysfunction play a major role in tumour suppression, whereas telomere shortening contributes to the initiation of cancer by inducing chromosomal instability. Since stem cells are exposed to various tumourigenic agents and stresses throughout their lifetime, the ageing stem cell is a major target of malignant transformation. This review summarises our knowledge of telomere length and telomerase activity in stem cells during ageing and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644207     DOI: 10.1016/j.ejca.2006.01.040

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

Review 1.  Cancer stem cells: relevance to clinical transplantation.

Authors:  Gabriel Ghiaur; Jonathan M Gerber; William Matsui; Richard J Jones
Journal:  Curr Opin Oncol       Date:  2012-03       Impact factor: 3.645

2.  CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

Authors:  Sallyann L O'Brien; Ailís Fagan; Edward J P Fox; Robert C Millikan; Aedín C Culhane; Donal J Brennan; Amanda H McCann; Shauna Hegarty; Siobhan Moyna; Michael J Duffy; Desmond G Higgins; Karin Jirström; Göran Landberg; William M Gallagher
Journal:  Int J Cancer       Date:  2007-04-01       Impact factor: 7.396

3.  Age-related changes in subtelomeric methylation in the normal Japanese population.

Authors:  Toyoki Maeda; Jing Zhi Guan; Jun-ichi Oyama; Yoshihiro Higuchi; Naoki Makino
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-17       Impact factor: 6.053

Review 4.  Stem cell function and maintenance - ends that matter: role of telomeres and telomerase.

Authors:  Hamid Saeed; Mehwish Iqtedar
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

5.  The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.

Authors:  Raja Mzahma; Maher Kharrat; Fadhel Fetiriche; Mounir Ben Moussa; Zoubeir Ben Safta; Chadli Dziri; AbdelJelil Zaouche; Habiba Chaabouni-Bouhamed
Journal:  Tumour Biol       Date:  2015-06-06

6.  The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells.

Authors:  Jillian E Koziel; Brittney-Shea Herbert
Journal:  Breast Cancer Res Treat       Date:  2015-01-28       Impact factor: 4.872

7.  Alterations of telomere length in human brain tumors.

Authors:  Majid Kheirollahi; Masoud Mehrazin; Naser Kamalian; Parvin Mehdipour
Journal:  Med Oncol       Date:  2010-04-07       Impact factor: 3.064

8.  Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.

Authors:  Xiaochun Zhang; Ritsuko Komaki; Li Wang; Bingliang Fang; Joe Y Chang
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

Review 9.  Stem cell markers in gliomas.

Authors:  Paola Dell'Albani
Journal:  Neurochem Res       Date:  2008-05-21       Impact factor: 3.996

Review 10.  Cancer stem cells-clinical relevance.

Authors:  Richard J Jones
Journal:  J Mol Med (Berl)       Date:  2009-10-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.